Professor Wen Jiang
Prosiectau fel Prif Ymchwiliwr
- The molecular, cellular and clinical impacts of SOCS suppressor of cytokine signalling in human wound healing (18.01.2012 - 17.01.2015)
- Tumour stroma in prostate cancer (01.10.2011 - 30.11.2018)
- Validation of nWASP (neural Wiskott-Aldrich Syndrome Protein) as a therapeutic target in chronic non-healing human wounds (01.01.2014 - 31.12.2016)
- Validation of nWASP (Neuronal Wiskott-Aldrich Syndrome Protein) as a therapeutic target in chronic and non-healing human wounds (01.01.2014 - 30.06.2017)
- Wound genetics prognostic (01.01.2016 - 30.06.2016)
Prosiectau fel Cyd-Ymchwiliwr
- Cardiff Experimental Cancer Medicine Centre (01.04.2007 - 31.03.2012)
- Functional role of epithelial protein lost in neoplasm (EPLIN) in prostate cancer metastasis (01.10.2014 - 30.09.2017)
- HAVcR-1 and the prevention of metastatic disease in human prostate cancer (01.10.2014 - 30.09.2017)
- Targeting alpha-beta - crystalline (CRYAB): A novel strategy to impede triple-negative breast cancer development (01.07.2014 - 31.01.2016)
- The molecular, cellular and clinical impacts of SOCS: Suppressor of cytokine signalling in human wound healing (01.10.2013 - 31.12.2016)